British American Tobacco consensus in focus, shares steady on London trade

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-30, 09:30.

British American Tobacco (GB0002875804) starts this Tuesday with a stable presence on the London Stock Exchange and a long-established role in global consumer staples. The stock remains a core income holding in the FTSE universe, supported by a high dividend yield and broad analyst coverage.

How analysts view BAT now

Across major research houses, British American Tobacco is typically covered as a mature tobacco and nicotine player with a focus on cash generation and shareholder returns. Analysts often highlight the company’s dividend yield, which has historically sat in the mid-single-digit to high-single-digit percentage range, alongside a progressive payout policy anchored in annual earnings.

Consensus ratings on BAT have in recent months tended to cluster around Hold to Buy, reflecting the tension between regulatory and volume headwinds and the defensive appeal of steady cash flows. Price targets in many published models generally assume low-single-digit underlying revenue growth and margin resilience, rather than aggressive expansion or contraction.

Key themes in recent coverage

Recent analyst work on British American Tobacco has prominently discussed the balance between its legacy combustible cigarette portfolio and its newer categories such as vapour, heated tobacco and modern oral nicotine. In many models, analysts treat next-generation products as a strategic investment area, expecting them to take a gradually rising share of group revenues over the medium term.

Valuation commentary for BAT frequently compares the stock with peers like Imperial Brands and Philip Morris International, noting that British American Tobacco often trades at a discount in terms of price-to-earnings multiples despite similar or higher dividend yields. That spread is usually explained by geographic exposure, litigation risk perceptions and differing views on the pace of reduced-risk product adoption.

Where BAT makes its money

British American Tobacco generates most of its revenue from the manufacture and sale of cigarettes and other combustible tobacco products under brands such as Dunhill, Lucky Strike and Rothmans. Alongside these, the group has expanded into vapour and heated-tobacco devices and modern oral nicotine pouches, aiming to diversify its portfolio toward products positioned as reduced-risk alternatives by some regulators.

Where the stock trades today

British American Tobacco shares (GB0002875804) are listed on the London Stock Exchange, with trading and price formation in pounds sterling. As of 2026-06-30, 09:30, investors continue to treat BAT as a large-cap FTSE tobacco stock with a pronounced income profile rather than a high-growth equity.

This text is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or a solicitation of any kind. All data and assessments are subject to change without notice.